Skip Navigation



Carcinogenesis Advance Access published online on September 16, 2004

Carcinogenesis, doi:10.1093/carcin/bgh281
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
26/1/119    most recent
bgh281v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Paul, B.
Right arrow Articles by Gilmour, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paul, B.
Right arrow Articles by Gilmour, S. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received June 3, 2004
Revised August 5, 2004
Accepted September 5, 2004

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice1

Barry Paul 1, Candace S. Hayes 1, Arianna Kim 2, Mohammad Athar 2, and Susan K. Gilmour 1*

1 Lankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096
2 Department of Dermatology, Columbia University, 630W 168th St, New York, New York 10032

* To whom correspondence should be addressed. E-mail: gilmours{at}mlhs.org.


   Abstract

Tea polyphenolic constituents induce apoptosis in cancer cells but not in normal cells. To study the mechanism of this selective effect, we used the ODC/Ras double transgenic mouse model that develops spontaneous skin tumors due to overexpression of ornithine decarboxylase (ODC) and a v-Ha-ras transgene. Administration of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) in the drinking water significantly decreased both tumor number and total tumor burden compared to untreated ODC/Ras mice without decreasing the elevated polyamine levels present in the ODC/Ras mice. EGCG selectively decreased both proliferation and survival of primary cultures of ODC overexpressing transgenic keratinocytes but not keratinocytes from normal littermates nor ras-infected keratinocytes. This decreased survival was due to EGCG-induced apoptosis and not terminal differentiation. Moreover, in skin from EGCG-treated ODC transgenic mice, caspase 3 (active form) was detected only in epidermal cells that possess very high levels of ODC protein. Since most transformed cells and tumor tissue possess higher levels of polyamines compared to normal cells or tissue, our data suggest that the elevated levels of polyamines in tumor cells sensitize them to EGCG-induced apoptosis. These results suggest that EGCG may be an effective chemopreventive agent in individuals with early, preneoplastic stages of cancer having higher levels of polyamines.

Keywords: polyamines; ornithine decarboxylase; (-)-epigallocatechin-3-gallate; skin carcinogenesis; apoptosis.

1 Supported by grants CA070739 and CA97249 from the National Cancer Institute


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
H.-C. Huang, T.-D. Way, C.-L. Lin, and J.-K. Lin
EGCG Stabilizes p27kip1 in E2-Stimulated MCF-7 Cells through Down-Regulation of the Skp2 Protein
Endocrinology, December 1, 2008; 149(12): 5972 - 5983.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.